• Malignant Neoplasm, Fallopian tube
  • Mini Respiratory Pathogen Panel (Influenza A and B and SARS-CoV-2), Molecular
  • Pulmonary arterial hypertension
  • Gentamicin, Trough, Serum
  • Familial Adenomatous Polyposis (APC) Gene Mutation Analysis
  • Microtubule-Associated Protein Tau (MAPT), Mutation Analysis
  • Malignant neoplasm, renal pelvis (kidney)
  • Toxocariasis
  • Galactosemia
  • Cholera
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
Medical Test

CPT
Access to Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis is restricted.